pulseTV

VIDEO: Advances in Cardiac MRI Technology

James Carr, M.D., chair of the Department of Radiology, Northwestern University, and incoming 2020 President of the Society of Cardiac Magnetic Resonance (SCMR), explains why MRI is an ideal cardiac imaging modality, at the 2019 Radiological Society of North America (RSNA) meeting.

Heart MRI offers advantages over computed tomography (CT) and echocardiography because of its excellent soft tissue delineation and its ability to offer information beyond anatomical imaging, such as perfusion, morphology and metabolism. MRI can be technically challenging and the exams requiring a long time, but recent advances have helped cur cardiac imaging times down significantly. Automation and artificial intelligence (AI) also is making post-processing and quantification mush faster, brining it closer to the time it takes to scan and post-process CT imaging.

Northwestern is was one of the early adopters of cardiovascular MRI. Carr said heart MRI was not common in regular clinical use until the past decade at some luminary centers. In 2005, Carr was given the opportunity to develop a clinical cardiac MRI program at Northwestern.
 
He said MRI scanners have improved, and now much faster than a decade ago. They are also more optimized for cardiac imaging. While heart MRI is well known in large hospital centers, Carr said it still needs to develop and expand to community hospitals and rural hospitals outside major population centers. 

Artificial intelligence is playing a significant role in cardiac MRI automation of speeding workflow and quantification. Carr said these technologies will become mainstream in the next few years. AI also will play an increasing role in risk prediction based on new image analysis algorithms in development.

For more information on cardiac MRI, visit SCMR's website www.heartmri.org.

 

Related Cardiac MRI Content:

Cardiac MRI Delivers Accurate Diagnosis for Frontline Chest Pain Evaluation

Cardiac MRI Becoming More Widely Available Thanks to AI and Reduced Exam Times

VIDEO: Dedicated Cardiac MRI Use at the Baylor Scott White Heart Hospital — Interview with Haojie Wang, M.D.

VIDEO: Dedicated Cardiac MRI Use at the Baylor Scott White Heart Hospital

Advantages and New Applications of Cardiac MRI

Will Cardiac MRI Expand?

VIDEO: Use of Cardiac MRI in Congenital and Women's Heart Disease — Karen Ordovas, M.D., 
 

 

Conference Coverage

Cardiovascular Ultrasound | July 03, 2018

Michael Lanspa, M.D., director of critical care echocardiography services, Intermountain Medical Center, Salt Lake City, Utah, explains the training initiatives by the American Society of Echocardiography (ASE) for point-of-care ultrasound. Lanspa serves on the educational committees for ASE, the American Thoracic Society (ATS) and the Society of Critical Care Medicine. 

POC ultrasound was discussed as one of the big recent developments at ASE 2018

Cardiovascular Ultrasound | July 02, 2018

Lissa Sugeng, M.D., associate professor of medicine, director of echocardiography and of the Yale Echo Core Lab, Yale School of Medicine, explains the advances and advantages of using 3-D cardiac ultrasound during the American Society of Echocardiography (ASE) 2018 meeting. She said 3-D echo still has slower frame rates than 2-D, but offers some advantages. Sugeng said echo labs should consider adding at least 3-D machine, as this technology will become the way of the future in echo. Read more about recent advances in cardiac ultrasound. 

Cardiovascular Ultrasound | July 02, 2018

This is an example of the a mitral valve with regurgitation imaged with 3-D echocardiography using the Siemens SC2000 cardiac ultrasound system. The first video clip shows the 3-D anatomy of the heart, the mitral valve, its leaflet cusps tabled and the left ventricular outflow track (LVOT) of the aortic valve. The second clip shows how the software can automatically extract and quantify the regurgitant volume. The last clip shows an isolation of the mitral valve and the regurgitant jet, showing the exact location of the source, which can be used aid surgical planning. This video was shot at the American Society of Echocardiography (ASE) 2018.

Find additional technology video clips, video interviews and news from ASE.

 

Cardiovascular Ultrasound | June 28, 2018

Sunil Mankad, M.D., FASE, ASE 2018 meeting program chair and director of transesophageal echocardiography at Mayo Clinic, Rochester, Minn., explains four big trends in cardiac ultrasound during the American Society of Echocardiography (ASE) 2018 meeting. These include the advancement of 3D echo, point-of-care ultrasound, artificial intelligence and new forms of image visualization. Read more about recent advances in cardiac ultrasound. 

Cardiovascular Ultrasound | June 28, 2018

This is a demonstration of the the Philips TrueVue photo-realistic rendering and lighting source technology. This example highlights a transcatheter ASD closure with two Amplatzer occluders. The technology allows users to changing the lighting conditions to improve contrast. The light source can also be moved around to change the shadows and add more depth perception. The light source also can be pushed through the tissue to back light the anatomical structures, as shown in this example at the American Society of Echocardiography (ASE) 2018 meeting. The backlighting confirms a gap at the top of the image where part of the septal defect remains exposed. 

Find more videos and news from ASE 

Cardiovascular Ultrasound | June 11, 2018

Thomas Porter, M.D., professor of medicine and director of the echocardiography lab at the University of Nebraska Medical Center, discusses potential therapeutic uses for microbubble contrast ultrasound at the 2017 American Society of Echocardiography (ASE) annual meeting.

Enterprise Imaging | April 26, 2018

Organizations who are embarking on an enterprise imaging journey share many of the same questions and concerns regarding how to best optimize workflow across providers, departments and facilities; which technologies will provide the best fit for achieving the future vision; and how to maximize value and accelerate return on investment by driving adoption and improving satisfaction among providers and healthcare consumers (patients).

We, Paragon Consulting Partners LLC (PCP Imaging), are a team of passionate healthcare professionals that bring over 100 years of collective clinical, technical and business leadership experience within the healthcare IT and imaging informatics industries. In this video we address the key challenges and considerations faced by organizations undertaking an Enterprise Imaging journey, and how a trusted partner can contribute valuable expertise and guidance that enable healthcare organizations and vendors of any size to successfully tackle even their most challenging enterprise imaging initiatives. For more information, visit pcpimaging.com.

Cath Lab | March 27, 2018

Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional cardiovascular research and clinical trials at the Zena and Michael A. Wiener Cardiovascular Institute at Mount Sinai School of Medicine. She spoke on how to avoid acute kidney injury (AKI) and contrast-induced nephropathy (CIN) using various strategies in the cath lab to reduce iodine contrast use at the American College of Cardiology (ACC) 2018 meeting. 

 

 

Related CIN Content:

Sliding Scale Hydration Washes Out Contrast-Induced Kidney Complications

Contrast-Induced Kidney Injury Prevented With RenalGuard in REMEDIAL III Trial

VIDEO: How to Avoid Acute Kidney Injury in the Cath Lab — Interview with Hitinder Gurm, M.D.

VIDEO: Combating Contrast Induced Nephropathy in the POSEIDON Trial — Presentation by Sonjot Brar, M.D.
 

 

Intravascular Imaging | March 27, 2018

A discussion with Ron Waksman, M.D., associate director of the division of cardiology and director of cardiovascular research and advanced education at MedStar Heart Institute, and professor of medicine (cardiology) at Georgetown University. He explained the ongoing clinical trials using near infrared spectroscopy to detect lipid rich plaque in the coronary arteries. He spoke to DAIC at the 2018 American College of Cardiology (ACC) meeting.

Find out the late-breaking results of the LRP Study in a VIDEO with Waksman at TCT 2018. 

 

Heart Failure | March 23, 2018

David Lanfear M.D., FACC, head of advanced heart failure and cardiac transplantation, Henry Ford Hospital, Detroit, discusses LVAD support technologies at the 2018 American College of Cardiology (ACC) meeting. Read the article “Device Technologies to Reduce Heart Failure Readmissions.” Watch the VIDEO “Technologies to Reduce Heart Failure Readmissions,” an interview with William Abraham, M.D., The Ohio State University Wexner Medical Center.

Additional articles and videos on Henry Ford Hospital 

ACC | March 21, 2018

DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at the 2018 meeting of the American College of Cardiology (ACC). Find links to other videos and the ACC 2018 Late-Breaking Trials.
 

 

Womens Cardiovascular Health | March 21, 2018

A discussion with Doreen DeFaria Yeh, M.D., associate director, Massachusetts General Hospital Adult Congenital Heart Disease Program and MGH Cardiovascular Disease and Pregnancy Service, at the 2018 American College of Cardiology (ACC) meeting. Yeh explains the differences between men and women for the clinical presentation of heart attacks and other causes for chest pain.  

 

Related Women's Heart Health Content:

Diagnostic Differences in Women’s Heart Health

VIDEO: Differences in Cardiac Complications and Presentation Between Men and Women — Interview with Cindy Grines, M.D.

DAIC's Women's Cardiovascular Health Channel

VIDEO: How to Build a Successful Women’s Heart Center — Interview with Malissa Wood, M.D.

VIDEO: Creating a Cardio-Obstetrics Team — Doreen DeFaria Yeh, M.D.

Congenital Heart | March 20, 2018

A discussion with Ami Bhatt, M.D., director of the adult congenital heart program and outpatient cardiology, Massachusetts General Hospital, at the 2018 American College of Cardiology (ACC) meeting. Here is some additional related content on adult congenital heart disease:

Many People with Congenital Heart Disease Living Longer

Adult Congenital Heart Disease Designated as Subspecialty

VIDEO: How Transcatheter PFO Closure Can Reduce Cryptogenic Stroke

 

Cath Lab | March 15, 2018

A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer, University of Michigan Health System, at the 2018 American College of Cardiology (ACC) meeting.  For more information, read the article "Understanding Contrast-Induced Nephropathy." He discusses various strategies to help reduce iodine contrast use in the cath lab to better protect patients from CIN.

 

Related CIN Content:

Sliding Scale Hydration Washes Out Contrast-Induced Kidney Complications

Contrast-Induced Kidney Injury Prevented With RenalGuard in REMEDIAL III Trial

VIDEO: Strategies to Avoid Acute Kidney Injury Caused by Cath Lab Contrast — Interview with Roxana Mehran, M.D.

VIDEO: Combating Contrast Induced Nephropathy in the POSEIDON Trial — Presntation by Sonjot Brar, M.D.

 

Heart Valve Technology | March 15, 2018

Insights from the STS/ACC TVT Transcatheter Valve Registry, presented at the American College of Cardiology (ACC) 2018 meeting by Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital. See the following related content for other insights into transcatheter aortic valve replacement technology:

VIDEO: Clinical Outcomes With the Lotus TAVR Valve

CoreValve TAVR System Shows Strong Long-Term Performance in Clinical Trials

VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis

VIDEO: Conscious Sedation for TAVR Procedures

VIDEO: Transcaval Access in TAVR Procedures

• VIDEO: TAVR for Degenerated Surgical Valves — Valve-in-Valve TAVR Procedures

FFR Technologies | March 15, 2018

An economic analysis of the DEFINE-FLAIR study comparing FFR vs. iFR, found a cost savings of nearly $900. The late-breaking session was presented at the 2018 American College of Cardiology (ACC) meeting by Manesh Patel, M.D., investigator and member of the study steering committee, and chief, division of cardiology, Duke University. Read more about the economic study.

 

Related FFR vs. iFR Content:

VIDEO on the 2017 results of the DEFINE-FLAIR and SWED-HEART iFR vs. FFR trials

iFR More Cost-Effective Than FFR in PCI Guidance 

Easier to Use iFR Equal to Outcomes of FFR in Coronary Lesion Evaluation

New Technology Directions in Fractional Flow Reserve (FFR)

VIDEO: iFR Equal to FFR Outcomes in Coronary Lesion Evaluation

European Society of Cardiology Incorporates iFR Technology Into Updated Revascularization Guidelines

 

Heart Valve Technology | March 02, 2018

Sammy Elmariah, M.D., MPH, interventional structural heart disease, Massachusetts General Hospital, discusses the progression of using transcatheter heart valves to replace surgical valves at ACC.17. See the following related content for other insights into transcatheter aortic valve replacement technology:

 VIDEO: Clinical Outcomes With the Lotus TAVR Valve

• CoreValve TAVR System Shows Strong Long-Term Performance in Clinical Trials

• VIDEO: TAVR For Asymptomatic Severe Aortic Stenosis

• VIDEO: Conscious Sedation for TAVR Procedures

• VIDEO: Transcaval Access in TAVR Procedures

 

Radial Access | February 16, 2018

The father of transradial artery access, Ferdinand Kiemeneij, M.D., Ph.D., interventional cardiologist, The Netherlands, explains how and why he first implemented the use of radial access and explains how the technique expanded beyond his cath lab to spread around the world. Read the article "Transradial Access Celebrates 25 Years". Watch the VIDEO "New Frontiers in Radial Access."

Keep up to date on radial access news with DAIC's radial access channel. 

Cath Lab | January 04, 2018

Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif., and former cardiology department manager at the cardiac cath lab at the Jesse Brown VA Medical Center in Chicago, offers insights from her SCAI Boot Camp presentation at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. She discusses implementing new techniques and technologies, drawing from her experience implementing radial access programs. Here are links to a couple articles she wrote on the topic “Tips When Prepping for Radial Procedures” and “How to Contend With Transradial Artery Perforation.”

Heart Valve Technology | January 04, 2018

Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how his center is already performing off-label transcatheter mitral valve implantations in patients who otherwise have no more options. He also discusses some of the new transcatheter mitral valve technologies in development. Watch the VIDEO “Mitral and Tricuspid Valve Repair Technologies.”  Watch a VIDEO of Greenbaum explaining his use of venous-to-aortic transcaval access in TAVR.

Additional articles and videos on Henry Ford Hospital 

Cardiac Imaging | December 29, 2017

ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the expo floor at the 2017 Radiological Society of North America (RSNA) meeting. Watch the editor’s choice video for new health IT technologies at HIMSS 2017, new advances in cardiac ultrasound at ASE 2017, and CT advances at the SCCT 2017 meeting.

Magnetic Resonance Imaging (MRI) | December 13, 2017

Emanuel Kanal, M.D., director of MRI services and professor of radiology and neuroradiology at the University of Pittsburgh Medical Center, explains the new mobile application he developed, which lets users visually model the forces at work during an MRI exam on patients with implanted medical devices, at the 2017 Radiological Society of North America (RSNA) meeting.

Read the related article “The Changing Relationship Between MRIs and Pacemakers.”

Advanced Visualization | December 07, 2017

Dianna Bardo M.D., director of body MR and co-director of the 3-D Innovation Lab at Phoenix Children's Hospital, discusses how 3-D printing and other advanced imaging modalities can help improve outcomes in complex cases. Read the article “The Use of 3-D Printing in Cardiology.” Watch the WEBINAR “Innovation and Success in 3D-inspired Development of the Business and Clinical Practice,” presented by Bardo.

 

 

Angiography | November 22, 2017

Shimadzu demonstrated its Trinias Interventional X-ray System at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. The system offers several features to enable improved patient access and procedural guidance at a lower radiation dose than previous generation angiography systems. For more information visit www.shimadzu.com/med/products/angio.

Radial Access | November 22, 2017

Mladen I. Vidovich, M.D., FACC, FSCAI, chief, section of cardiology, Jesse Brown VA Medical Center, Chicago, and associate professor of medicine at the University of Illinois at Chicago, discusses some of the current techniques and issues involved with radial artery access. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read articles he authored, including “Radiation Exposure Related to Transradial Access” and “Vascular Closure Devices Aid Closure of Large Access Sites.”

Find more news and on transradial access technique and technology

 

Medical 3-D Printing | November 17, 2017

Dee Dee Wang, M.D., director, structural heart imaging at Henry Ford Hospital, Detroit, explains how her center uses 3-D printing and computer aided design (CAD) software to improve patient outcomes. She spoke to DAIC at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read the articles “The Use of 3-D Printing in Cardiology” and “Henry Ford Hospital Study Shows 3-D Imaging Improves Fixing Broken Hearts.”  

Additional articles and videos on Henry Ford Hospital 

Stents Bifurcation | November 15, 2017

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains his experience with the Tryton Side Branch stent in both clinical practice and as an investigator in the Tryton Pivotal IDE Trial. Read the article “Data Published for Pivotal Trial for Tryton Side Branch Stent,” and about the regulatory clearance “FDA Clears First Dedicated Coronary Bifurcation Stent.”

TCT | November 15, 2017

DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiovascular Therapeutics (TCT). Hear what Cardiovascular Research Foundation (CRF) President and CEO Juan Granada, M.D., feels are the hottest technologies to watch. 

FFR Technologies | November 15, 2017

A discussion with William Fearon, M.D. director of interventional cardiology, Stanford University Medical Center, about the FAST-FFR Trial he is heading. It is comparing wire-based fractional flow reserve (FFR) to angiography image-derived FFR. The technology may open the door to wider use of FFR by eliminating costs, disruption and extra time in the cath lab workflow, the use of pressure wires and eliminate the need for adenosine. 

 

Related FFR-Angio Content:

FAST-FFR Trial of FFR-angio Technology Meets Primary Endpoint, Exceeded Performance Goals at TCT 2018

CathWorks Receives CPT Code for Non-invasive FFRangio Measurements During PCI

Heart Valve Technology | November 15, 2017

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigator for the Lotus valve’s U.S. pivotal trial. He explains what the clinical data to date has been for this new transcatheter aortic valve replacement (TAVR) device, which will likely become the third available on the U.S. market. Read the article "Lotus TAVR System Shows Superior Efficacy to CoreValve in Global REPRISE III Trial."

 

Left Atrial Appendage (LAA) Occluders | November 14, 2017

Vivek Reddy, M.D., director of cardiac arrhythmia services and professor of medicine, cardiology, Mount Sinai Hospital, N.Y., explains the latest Watchman left atrial appendage (LAA) occluder study data presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference.

Watch the VIDEO “Post-FDA Approval Experience of LAA Occluders,” with David Holmes, M.D.

Watch a VIDEO interview with Reddy at Heart Rhythm Society (HRS) 2017 on leadless pacing technologies

Cardiovascular Business | November 09, 2017

A discussion with Peter L. Duffy, M.D., MMM, FACC, FSCAI CPE, interventional cardiologist and former director of quality for the cardiovascular service line at FirstHealth of the Carolinas Reid Heart Institute, at Moore Regional Hospital in Pinehurst, N.C. Read the article with Duffy “Interventional Cardiologist Redefines Value for Everyday Medical Practice.” Read the article “Preparing Hospitals for Mandatory Medicare Cardiac Bundled Payments.”

Hemodynamic Support Devices | November 09, 2017

A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, about the creation of a national initiative to start percutaneous hemodynamic support first before beginning revascularization. O’Neill started the Detroit Cardiogenic Shock Initiative with several hospitals in 2016 and saw a 50 percent drop in mortality. Read the article “Detroit Cardiogenic Shock Initiative Goes National at TCT 2017.” Watch the VIDEO “Cardiogenic Shock Supported With Impella Shows Good Outcomes.”

 

Related Cardiogenic Shock Content:

VIDEO: How to Reduce Cardiogenic Shock Mortality by 50 Percent — Interview with h Babar Basir, D.O.

SCAI Releases New Consensus Document on Classification Stages of Cardiogenic Shock

VIDEO: The Importance of Ventricular Unloading in AMI and Cardiogenic Shock — Interview with Nevin Kapur, M.D.

10 Reasons Why it is Time to Learn More About Cardiogenic Shock — by Emmanouil S. Brilakis, M.D.

New Approaches to Reduce Cardiogenic Shock Mortality

 

Additional articles and videos on Henry Ford Hospital 

Structural Heart Occluders | November 08, 2017

John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the principal investigator for the REDUCE Trial, the FDA pivotal study using the Cardioform for PFO closure to prevent cryptogenic stroke. He discusses some of the data showing benefit for patients and debate around all the trials for PFO closure.

The FDA cleared the additional indication for PFO in April 2018.

Read about the results of the REDUCE trial in the article “PFO Closure Shows Positive Results from REDUCE Clinical Study.” Read about the approval of the first PFO closure device in 2016.  Watch the VIDEO "Addressing Adult Congenital Heart Referrals."

 

Related PFO Closure Content:

SCAI Offers Recommendations for Safe Use of PFO Closure Technologies

VIDEO: An Overview of PFO Closure to Treat Cryptogenic Stroke — Interview with Karen Orjuela, M.D.

VIDEO: Transcatheter Closure of Holes in the Heart — Interview with Ziyad Hijazi, M.D.

VIDEO: Demonstration of a Transcatheter PFO Occluder Implantation

VIDEO: Addressing Adult Congenital Heart Referrals — Interview with Ami Bhatt, M.D.

 

 

Cath Lab | November 08, 2017

Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on what technologies he predicts will become main stream therapies in the coming years. DAIC spoke to him at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) conference. Read the article “The Future of Cardiology: 17 Technologies to Watch.” Watch other VIDEOS with Granada, “Transcatheter Mitral Valve Therapies in Development.” “The Evolution of TAVR Technology,” and “Bioresorbable Stent Failure Modes, Technique, Patient Selection and Future Development.”

Heart Valve Technology | November 08, 2017

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System, explains the EARLY TAVR trial evaluating the use of transcatheter aortic valve replacement compared to surveilLance for patients With asymptomatic severe aortic stenosis. Genereux is the principal investigator for the trial. Read more about the EARLY TAVR trial

Heart Valve Technology | November 08, 2017

Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the MAVERIC Trial six-month outcomes using the Arto System at a press conferences at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual meeting. Read more about the trial in the article “Arto System Shows Promise as Less-Invasive Therapy for Heart Failure Patients.” Watch a VIDEO interview with Worthley on “Drug-Filled Stents as an Alternative to Polymer Drug Carriers.” 

Overlay Init